82 related articles for article (PubMed ID: 10508932)
1. Co-operativity between modules within a C3b-binding site of complement receptor type 1.
Kirkitadze MD; Dryden DT; Kelly SM; Price NC; Wang X; Krych M; Atkinson JP; Barlow PN
FEBS Lett; 1999 Oct; 459(1):133-8. PubMed ID: 10508932
[TBL] [Abstract][Full Text] [Related]
2. Central modules of the vaccinia virus complement control protein are not in extensive contact.
Kirkitadze MD; Henderson C; Price NC; Kelly SM; Mullin NP; Parkinson J; Dryden DT; Barlow PN
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):167-75. PubMed ID: 10548547
[TBL] [Abstract][Full Text] [Related]
3. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
Wong WW; Farrell SA
J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
[TBL] [Abstract][Full Text] [Related]
4. Independently melting modules and highly structured intermodular junctions within complement receptor type 1.
Kirkitadze MD; Krych M; Uhrin D; Dryden DT; Smith BO; Cooper A; Wang X; Hauhart R; Atkinson JP; Barlow PN
Biochemistry; 1999 Jun; 38(22):7019-31. PubMed ID: 10353813
[TBL] [Abstract][Full Text] [Related]
5. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.
Krych M; Hourcade D; Atkinson JP
Proc Natl Acad Sci U S A; 1991 May; 88(10):4353-7. PubMed ID: 1827918
[TBL] [Abstract][Full Text] [Related]
6. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
[TBL] [Abstract][Full Text] [Related]
7. Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria.
Tetteh-Quarcoo PB; Schmidt CQ; Tham WH; Hauhart R; Mertens HD; Rowe A; Atkinson JP; Cowman AF; Rowe JA; Barlow PN
PLoS One; 2012; 7(4):e34820. PubMed ID: 22506052
[TBL] [Abstract][Full Text] [Related]
8. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
Kalli KR; Hsu PH; Bartow TJ; Ahearn JM; Matsumoto AK; Klickstein LB; Fearon DT
J Exp Med; 1991 Dec; 174(6):1451-60. PubMed ID: 1836011
[TBL] [Abstract][Full Text] [Related]
9. Deciphering complement receptor type 1 interactions with recognition proteins of the lectin complement pathway.
Jacquet M; Lacroix M; Ancelet S; Gout E; Gaboriaud C; Thielens NM; Rossi V
J Immunol; 2013 Apr; 190(7):3721-31. PubMed ID: 23460739
[TBL] [Abstract][Full Text] [Related]
10. Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor.
Smith BO; Mallin RL; Krych-Goldberg M; Wang X; Hauhart RE; Bromek K; Uhrin D; Atkinson JP; Barlow PN
Cell; 2002 Mar; 108(6):769-80. PubMed ID: 11955431
[TBL] [Abstract][Full Text] [Related]
11. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
Subramanian VB; Clemenza L; Krych M; Atkinson JP
J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of iC3b binding to human polymorphonuclear leucocytes.
Gordon DL; Johnson GM; Hostetter MK
Immunology; 1987 Apr; 60(4):553-8. PubMed ID: 2953669
[TBL] [Abstract][Full Text] [Related]
13. A new map of glycosaminoglycan and C3b binding sites on factor H.
Schmidt CQ; Herbert AP; Kavanagh D; Gandy C; Fenton CJ; Blaum BS; Lyon M; Uhrín D; Barlow PN
J Immunol; 2008 Aug; 181(4):2610-9. PubMed ID: 18684951
[TBL] [Abstract][Full Text] [Related]
14. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
Porteu F; Mir A; Halbwachs-Mecarelli L
Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.
Birmingham DJ; Irshaid F; Gavit KF; Nagaraja HN; Yu CY; Rovin BH; Hebert LA
Mol Immunol; 2007 Jul; 44(14):3510-6. PubMed ID: 17467802
[TBL] [Abstract][Full Text] [Related]
16. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
Klickstein LB; Wong WW; Smith JA; Weis JH; Wilson JG; Fearon DT
J Exp Med; 1987 Apr; 165(4):1095-112. PubMed ID: 2951479
[TBL] [Abstract][Full Text] [Related]
17. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
18. p65: A C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor.
Wong WW; Fearon DT
J Immunol; 1985 Jun; 134(6):4048-56. PubMed ID: 2580903
[TBL] [Abstract][Full Text] [Related]
19. Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes. A CR1-like candidate for the immune adherence receptor.
Manthei U; Nickells MW; Barnes SH; Ballard LL; Cui WY; Atkinson JP
J Immunol; 1988 Feb; 140(4):1228-35. PubMed ID: 2963863
[TBL] [Abstract][Full Text] [Related]
20. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
Medof ME; Iida K; Mold C; Nussenzweig V
J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
